BSE: CIPLA - Cipla Limited

Yield per half year: -4.8%

Share chart Cipla Limited

Extended chart Simple chart
Financial Markets by TradingView

About

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments.

more details
It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN INE059A01026
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.5498
Дивиденд ао 13
Сайт https://www.cipla.com
Цена ао 1438.8
Change price per day: +0.0035% (1438.8)
Change price per week: -3.94% (1497.8)
Change price per month: -0.5873% (1447.35)
Change price per 3 month: -8.44% (1571.45)
Change price per half year: -4.8% (1511.35)
Change price per year: +9.61% (1312.75)
Change price per 3 year: +56.13% (921.55)
Change price per 5 year: +209.86% (464.35)
Change price per 10 year: 0% (1438.85)
Change price per year to date: -4.45% (1505.85)
All parameters

Underestimation

Title Value Grade
P/S 4.7 3
P/BV 4.46 4
P/E 29.01 6
EV/EBITDA 17.88 6
Total: 6

Efficiency

Title Value Grade
ROA, % 13.26 4
ROE, % 16.45 5
Total: 5

Dividends

Title Value Grade
Div yield, % 0.5498 1.38
DSI 1 10
Total: 3.84

Debt

Title Value Grade
Debt/EBITDA 0.0724 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 51.23 7
Yield Ebitda, % 49.05 6
Yield EPS, % 166.18 10
Total: 7.6
More

Head Job title Payment Year of birth
Dr. Raju Sunil Mistry M.A., Ph.D. President & Global Chief People Officer N/A 1965 (60 years)
Mr. Pradeep Bhadauria President & Global Chief Scientific Officer N/A
Mr. Ashish Adukia Global Chief Financial Officer N/A
Mr. Dinesh Ramniranjan Jain Senior VP & Head of Corporate Finance N/A
Mr. Naveen Bansal Head of Investor Relations N/A
Mr. Rajendra Kumar Chopra Compliance Officer & Company Secretary 15.3M
Ms. Heena Kanal Senior Vice-President of Corporate Communications N/A
Mr. Umang Vohra B.E., M.B.A. MD, Global CEO & Executive Director 1971 (54 years)
Ms. Sneha Hiranandani B Com Chief Information Officer
Dr. Jaideep A. Gogtay M.D., Ph.D. Global Chief Medical Officer 1967 (58 years)

Address: India, Mumbai, Cipla House - open in Google maps, open in Yandex maps
Website: https://www.cipla.com